Company / Working Capital per Share
Immunovant, Inc. Working Capital per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$4.07
FY2024
5-year range
$1.07 / $4.07
FY2020-FY2024
Trend
+55.7%
vs FY2023
Sector context
#125 of 212
Health Care
What the data says
At $4.07, Immunovant, Inc.'s working capital per share ranks #125 of 212 in the Health Care sector. Improved from $3.81 to $4.07 over the past 2 years.
Based on SEC 10-K filings.
4.07 in FY2024 with a 3-year CAGR of +4.6%.
Improved from $3.81 to $4.07 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +4.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#125 of 212 in Health CareTop 59% of 212This company $4.07 Sector average $117.56
▼
-96.5% below sector average
Key checks
Key Insights
- In FY2024, working capital per share increased 55.7% year-over-year.
- Ranks #125 out of 212 companies in the Health Care sector.
- Lowest working capital per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.07 | +55.7% |
| FY2023 | $2.61 | -31.3% |
| FY2022 | $3.81 | +7.0% |
| FY2021 | $3.56 | +233.0% |
| FY2020 | $1.07 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026